Two top docs rewarded for contribution to healthcare
May 2008
Two leading researchers at the University of Manchester have been elected to the Fellowship of the Academy of Medical Sciences.
Professor of Maternal and Fetal Health Philip Baker and Professor of Respiratory Medicine Ashley Woodcock OBE are among 40 new Fellows across the UK, elected for their outstanding contributions to the advancement of medical science, for innovative application of scientific knowledge and conspicuous service to healthcare.
Professor Philip Baker
Professor Baker's major research contributions have been to increase understanding and therapy of life-threatening pregnancy complications such as pre-eclampsia. He has also promoted the role of Magnetic Resonance Imaging in pregnancy and founded the University’s Maternal and Fetal Health Research Centre, now the largest obstetric research group in Europe, with the charity Tommy's.
Professor Baker is now Associate Dean for Research at the Faculty of Medical and Human Sciences, Head of Research and Innovation at Central Manchester and Manchester Children’s Hospital NHS Trust and Clinical Director of Manchester: Integrating Medicine and Innovative Technology (MIMIT), which brings clinicians and engineers together to solve medical problems and is the first international affiliate of the highly successful US centre CIMIT®. He also directs the newly awarded NIHR Biomedical Research Centre. He has been Chairman of the Blair Bell Research Society and served on the MRC Advisory Board.
Professor Ashley Woodcock
Professor Woodcock leads the Respiratory Research Group in the North West Lung Centre, an internationally recognised group in translational and clinical lung research. His research includes early life development of asthma and allergy, gene environment interactions and novel treatments for airway diseases such as COPD. He is also a Consultant Respiratory Physician at the University Hospital of South Manchester, where he is the Clinical Academic Lead.
Professor Woodcock helped an international panel of climate change experts win this year’s Nobel Prize for Peace. The prize was awarded jointly to the Intergovernmental Panel for Climate Change (IPCC) and former United States Vice President Al Gore. Professor Woodcock chaired the Medical Technical Options Committee, which investigated ozone-depleting chemicals in inhalers for patients with respiratory problems for the Montreal Protocol. He was also awarded the OBE in 2006 for his work with the Montreal Protocol.
He has also been Chairman of the Clinical Assembly of the European Respiratory Society, Chairman of the Royal College of Physicians Tobacco Committee and Public Education Officer of the British Thoracic Society.
The University of Manchester is not responsible for the content of external internet sites.
